the food and drug administration has recently approved the use of two new ophthalmic beta-adrenergic antagonistic agents : betaxolol hydrochloride ( betoptic ) and levobunolol hydrochloride ( betagan ) .
C0733365
levobunolol hydrochloride
C0591174
betagan